Literature DB >> 8015358

Morphine-3-glucuronide: silent regulator of morphine actions.

A W Lipkowski1, D B Carr, A Langlade, P F Osgood, S K Szyfelbein.   

Abstract

To assess whether stoichiometric manipulation of morphine (M) metabolism can enhance analgesia or slow the development of M tolerance we co-administered M-3- glucuronide (M3G) during single or repeated doses of morphine in rats. Although M3G itself lacked analgesic activity, co-injection of M3G with M increased and prolonged analgesia beyond that seen with M. In addition, diminution of the acute analgesic effect of M after 3 once-daily doses of M did not occur after daily co-injection of M3G and M. Thus the traditional view that tolerance to the effects of M is due solely to effects mediated through opioid receptors must be broadened to include the contributions of enzyme induction or stoichiometric equilibration of M3G in this process.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8015358     DOI: 10.1016/0024-3205(94)90106-6

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  7 in total

1.  Modification of morphine-induced hyperlocomotion and antinociception in mice by clorgyline, a monoamine oxidase-A inhibitor.

Authors:  Nobue Kitanaka; Junichi Kitanaka; Motohiko Takemura
Journal:  Neurochem Res       Date:  2006-06-23       Impact factor: 3.996

Review 2.  Candidate gene polymorphisms predicting individual sensitivity to opioids.

Authors:  Shinya Kasai; Masakazu Hayashida; Ichiro Sora; Kazutaka Ikeda
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-11-13       Impact factor: 3.000

Review 3.  Pharmacokinetics of opioids in liver disease.

Authors:  I Tegeder; J Lötsch; G Geisslinger
Journal:  Clin Pharmacokinet       Date:  1999-07       Impact factor: 6.447

4.  Sex-specific mediation of opioid-induced hyperalgesia by the melanocortin-1 receptor.

Authors:  Aaron Juni; Minying Cai; Magda Stankova; Amanda R Waxman; Caroline Arout; Gad Klein; Albert Dahan; Victor J Hruby; Jeffrey S Mogil; Benjamin Kest
Journal:  Anesthesiology       Date:  2010-01       Impact factor: 7.892

Review 5.  Morphine-3-Glucuronide, Physiology and Behavior.

Authors:  Florian Gabel; Volodya Hovhannisyan; Abdel-Karim Berkati; Yannick Goumon
Journal:  Front Mol Neurosci       Date:  2022-05-12       Impact factor: 6.261

6.  Morphine induces hyperalgesia without involvement of μ-opioid receptor or morphine-3-glucuronide.

Authors:  Maarten Swartjes; René A G Mooren; Amanda R Waxman; Caroline Arout; Koen van de Wetering; Jan den Hartigh; Jos H Beijnen; Benjamin Kest; Albert Dahan
Journal:  Mol Med       Date:  2012-12-06       Impact factor: 6.354

Review 7.  Biphalin-A Potent Opioid Agonist-As a Panacea for Opioid System-Dependent Pathophysiological Diseases?

Authors:  Patrycja Redkiewicz; Jolanta Dyniewicz; Aleksandra Misicka
Journal:  Int J Mol Sci       Date:  2021-10-21       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.